Immunohistochemistry for Prostate Biopsy—Impact on Histological Prostate Cancer Diagnoses and Clinical Decision Making

Immunohistochemistry for Prostate Biopsy—Impact on Histological Prostate Cancer Diagnoses and Clinical Decision Making

Background: To test the value of immunohistochemistry (IHC) staining in prostate biopsies for changes in biopsy results and its impact on treatment decision-making. Methods: Between January 2017–June 2020, all patients undergoing prostate biopsies were identified and evaluated regarding additional I...

Full description

Bibliographic Details
Main Authors: Philipp Mandel, Mike Wenzel, Benedikt Hoeh, Maria N. Welte, Felix Preisser, Tahir Inam, Clarissa Wittler, Clara Humke, Jens Köllermann, Peter Wild, Christoph Würnschimmel, Derya Tilki, Markus Graefen, Luis A. Kluth, Pierre I. Karakiewicz, Felix K.-H. Chun, Andreas Becker
Format: Article
Language:English
Published: MDPI AG 2021-06-01
Series:Current Oncology
Subjects:
immunohistochemistry
IHC
prostate cancer
radical prostatectomy
ASAP
Gleason Score
Online Access:https://www.mdpi.com/1718-7729/28/3/197

Internet

https://www.mdpi.com/1718-7729/28/3/197

Similar Items